These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18479077)

  • 1. [The ABC of viral hepatitis].
    Van Bambeke F
    J Pharm Belg; 2008 Mar; 63(1):15-20. PubMed ID: 18479077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Viral hepatitis B/C and HIV. Therapy of double infections].
    Mauss S
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():21-5. PubMed ID: 15011579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B genotypes and response to antiviral therapy: a review.
    Palumbo E
    Am J Ther; 2007; 14(3):306-9. PubMed ID: 17515708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus genotypes and response to antiviral therapy.
    Enomoto M; Tamori A; Nishiguchi S
    Clin Lab; 2006; 52(1-2):43-7. PubMed ID: 16506363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B: the pathway to recovery through treatment.
    Hollinger FB; Lau DT
    Gastroenterol Clin North Am; 2006 Jun; 35(2):425-61, x. PubMed ID: 16880074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy in patients with chronic hepatitis B and cirrhosis.
    Lai CJ; Terrault NA
    Gastroenterol Clin North Am; 2004 Sep; 33(3):629-54, x-xi. PubMed ID: 15324948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.
    Mutimer D
    J Hepatol; 2005 Aug; 43(2):200-2. PubMed ID: 15975684
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral options for the treatment of chronic hepatitis B.
    Osborn MK; Lok AS
    J Antimicrob Chemother; 2006 Jun; 57(6):1030-4. PubMed ID: 16595637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus.
    Bárcena R; Del Campo S; Moraleda G; Casanovas T; Prieto M; Buti M; Moreno JM; Cuervas V; Fraga E; De la Mata M; Otero A; Delgado M; Loinaz C; Barrios C; Dieguez ML; Mas A; Sousa JM; Herrero JI; Muñoz R; Avilés JF; Gonzalez A; Rueda M
    Transplant Proc; 2005 Nov; 37(9):3960-2. PubMed ID: 16386596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers.
    Renou C; Cadranel JF; Pariente A; Pénaranda G; Bourlière M; Halfon P; Igual JP; Harafa A; Muller P; Bertrand JJ; Laugier R
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1235-7. PubMed ID: 18989147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B therapy in children.
    Kurbegov AC; Sokol RJ
    Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):39-49. PubMed ID: 19210112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute hepatitis B: is antiviral therapy indicated? Two case reports].
    Girke J; Wedemeyer H; Wiegand J; Manns MP; Tillmann HL
    Dtsch Med Wochenschr; 2008 May; 133(22):1178-82. PubMed ID: 18491273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lamivudine and adefovir dipivoxil combination treatment for liver cirrhosis patients with CHB].
    Yang DH; Xie SF; Wang YM; Zhao NF; Li MW
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):473-4. PubMed ID: 18579006
    [No Abstract]   [Full Text] [Related]  

  • 14. [New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?].
    Petry W; Erhardt A; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Jan; 38(1):77-87. PubMed ID: 10689749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
    Jacob JR; Korba BE; Cote PJ; Toshkov I; Delaney WE; Gerin JL; Tennant BC
    Antiviral Res; 2004 Aug; 63(2):115-21. PubMed ID: 15302140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of chronic hepatitis B with primary adefovir resistance].
    Yamazhan T; Sertöz R; Pullukçu H; Taşbakan M; Ulusoy S; Erensoy S
    Mikrobiyol Bul; 2007 Apr; 41(2):297-301. PubMed ID: 17682718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic viral hepatitis.
    Ferenci P
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():113-20. PubMed ID: 15588803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adefovir dipivoxil--a further step in the control of chronic viral hepatitis B. There is still a long way to go].
    Husa P
    Vnitr Lek; 2004 Mar; 50(3):177-80. PubMed ID: 15125364
    [No Abstract]   [Full Text] [Related]  

  • 19. [Human immunodeficiency virus infection and viral hepatitis].
    Soriano V; Martin-Carbonero L; Vispo E; Labarga P; Barreiro P
    Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):691-701. PubMed ID: 21978797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine.
    Papatheodoridis GV; Dimou E; Dimakopoulos K; Manolakopoulos S; Rapti I; Kitis G; Tzourmakliotis D; Manesis E; Hadziyannis SJ
    Hepatology; 2005 Jul; 42(1):121-9. PubMed ID: 15962291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.